Halozyme Therapeutics (HALO) Acquisitions (2026)
Halozyme Therapeutics (HALO) posted quarterly Acquisitions of $710000.0 for Q1 2026.
Halozyme Therapeutics (HALO) Acquisitions (2026) Analysis & Trends
Halozyme Therapeutics (HALO) has reported Acquisitions for 1 consecutive years, with $710000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Acquisitions changed N/A year-over-year to $710000.0; the TTM figure through Mar 2026 stood at $710000.0 (changed N/A YoY), while the FY2025 annual figure was $726.0 million, changed N/A from the prior year.
- Acquisitions held at $710000.0 in Q1 2026 per HALO's latest filing.
- Across five years, Acquisitions topped out at $710000.0 in Q1 2026 and bottomed at $710000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Halozyme Therapeutics | 11.25 Bn | 11.02 Bn | 401.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 710,000.00 |